← Eichor
Condition: Therapy Related Toxicity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Therapy Related Toxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NA · 1 location(s) · Dena h. Al-Tameemi · NCT07273812Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06664528Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT05417737Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NA · 2 location(s) · Jessa Hospital · NCT04979078A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immu
Phase 2 · 11 location(s) · Canadian Cancer Trials Group · NCT03847649Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer:
Phase N/A · 1 location(s) · Fundación Pública Andaluza para la Investigación Biomédica A · NCT07582887RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Phase 1/Phase 2 · 3 location(s) · Georgetown University · NCT05256745Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06549621Chronic Toxicities Related to Treatment in Patients With Localized Cancer
NA · 1 location(s) · UNICANCER · NCT01993498Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Phase 2 · 10 location(s) · Rutgers, The State University of New Jersey · NCT05559164Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
Phase 2 · 1 location(s) · Yonsei University · NCT06677944Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic E
EARLY_Phase 1 · 1 location(s) · Peng Zhang · NCT06119490Study of Personalized Cancer Therapy to Determine Response and Toxicity
Phase N/A · 3 location(s) · Shu Mei Kato · NCT02478931A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
Phase N/A · 3 location(s) · FangYi · NCT07010939Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older
Phase N/A · 2 location(s) · University of Zurich · NCT07309497Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Phase 1/Phase 2 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT04700527LYell SYndrome MEsenchymal Stromal Cells Treatment
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04711200TDM for Optimized Outcome in Patients With mRCC.
Phase N/A · 1 location(s) · Niels Fristrup · NCT04659343Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07169487Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis
NA · 1 location(s) · University of Pavia · NCT07491536Impact of Gonadotoxic Therapies on Fertility
Phase N/A · 1 location(s) · Michael von Wolff · NCT05885048Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in
NA · 1 location(s) · Azienda Sanitaria Locale di Asti · NCT07524829Ofloxacin Concentration-toxicity Relationship in the Elderly
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT04496024Focal Therapy for Prostate Cancer Using HIFU
NA · 1 location(s) · University College, London · NCT01194648Early vs Delayed Intravesical Blad-Care During BCG Therapy
NA · 1 location(s) · BLAD-HYA Group · NCT07495072Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck
NA · 1 location(s) · Yvonne Mowery · NCT07227792Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Phase 2 · 9 location(s) · Matrix Biomed, Inc. · NCT03480971TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer
NA · 1 location(s) · The University of Hong Kong · NCT07484932
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.